IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance
(NASDAQ: ICCM) Delayed: 1.99 -0.07 (3.4%)
Previous Close $2.06    52 Week High $ 
Open $2.11    52 Week Low $ 
Day High $2.16    P/E N/A 
Day Low $1.96    EPS $ 
Volume 159,134